Initial research into the efficacy of Start suggests that after six weeks, 46 percent of users say they’re responding well to treatment, compared with 33 percent of patients prescribed antidepressants. The app allows users to track and report progress in real-time, which clinicians can then access and objectively measure.
THS clinicians receive regular updates in the form of faxes sent from the app, and can make comments on reports generated by Start. The developers say the app’s ability to track progress over time is likely to result in improved outcomes for patients with depression.
More articles on health IT:
Apple rumored to be developing health-monitoring gadget
What to do with all of that healthcare data?
Apple’s CareKit puts care management in patients’ hands & phones
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
